title: Nephron sparing surgery: A single institution experience.
abstract: OBJECTIVE
  To report our experience in managing various benign and malignant renal tumors with nephron-sparing surgery.
  
  
  METHODS
  Records of patients who underwent nephron-sparing surgery (NSS) either through open or laparoscopic approach between May 1997 and June 2006 at our institution were reviewed. Patient and tumor-related characteristics, treatment modality and complications were noted.
  
  
  RESULTS
  There were 26 patients (29 renal units), including three with bilateral lesions who underwent nephron-sparing surgery. Mean age at surgery was 47.0 years (range 16-67 years). Mean tumor size was 4.7 cm (range 2-7.5 cm). Mean warm ischemia time was 41 min and 32.5 min, operative time 158 min and 186 min and blood loss 200ml and 85 ml in open (n=24) and laparoscopic approach (n=2) respectively. Complications were seen in five (19.2%) patients of whom two had postoperative bleeding requiring nephrectomy in one and angioembolization in another. One patient with persistent urinary leak required intervention. Local wound infection in one patient and incisional hernia in another were surgically managed. Histopathological profile revealed 13 (44.8%) benign lesions which included angiomyolipoma (eight), simple cyst (two), cortical adenoma (one), metanephric adenoma (one) and myelolipoma (one). The remaining 16 (55.2%) malignant lesions included renal cell carcinoma (15) and metastatic adenocarcinoma (one). At a mean follow-up of 38.6 months (range 1-91) no patient had local recurrence or distant metastasis. Cancer-specific survival was 100% and overall survival was 92.3%.
  
  
  CONCLUSIONS
  Nephron-sparing surgery is a safe and effective alternative to nephrectomy in both benign and malignant lesions of the kidney.
authors.affiliation: Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Science, Lucknow, (UP), India.
authors.forename: S
authors.initials: S
authors.lastname: Agrawal
authors.forename: M S
authors.initials: MS
authors.lastname: Jha
authors.forename: N
authors.initials: N
authors.lastname: Khurana
authors.forename: M S A
authors.initials: MS
authors.lastname: Ansari
authors.forename: D
authors.initials: D
authors.lastname: Dubey
authors.forename: A
authors.initials: A
authors.lastname: Srivastava
authors.forename: R
authors.initials: R
authors.lastname: Kapoor
authors.forename: A
authors.initials: A
authors.lastname: Kumar
authors.forename: M
authors.initials: M
authors.lastname: Jain
authors.forename: A
authors.initials: A
authors.lastname: Mandhani
references.citation: Urology. 1980 Mar;15(3):219-28
references.pmid: 7361352
references.citation: Urology. 1999 Dec;54(6):994-8
references.pmid: 10604696
references.citation: Indian J Cancer. 2004 Jul-Sep;41(3):99-103
references.pmid: 15472406
references.citation: J Urol. 2000 Feb;163(2):442-5
references.pmid: 10647650
references.citation: J Urol. 1998 Sep;160(3 Pt 1):674-8
references.pmid: 9720519
references.citation: J Urol. 1999 Jan;161(1):33-4; discussion 34-5
references.pmid: 10037361
references.citation: J Clin Oncol. 1999 Sep;17(9):2868-75
references.pmid: 10561364
references.citation: J Urol. 1994 May;151(5):1177-80
references.pmid: 8158754
references.citation: J Urol. 1995 May;153(5):1409-14
references.pmid: 7714953
references.citation: Urology. 2002 Jun;59(6):816-20
references.pmid: 12031359
references.citation: Urology. 2004 Jul;64(1):31-4
references.pmid: 15245928
references.citation: BJU Int. 2005 Mar;95 Suppl 2:35-40
references.pmid: 15720333
references.citation: Cancer. 1997 Sep 1;80(5):992-3
references.pmid: 9307205
references.citation: Urology. 1995 Jan;45(1):34-40; discussion 40-1
references.pmid: 7817478
references.citation: Urology. 2001 Feb;57(2):252-6
references.pmid: 11182331